Viewing Study NCT00632268


Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-01-02 @ 1:42 PM
Study NCT ID: NCT00632268
Status: COMPLETED
Last Update Posted: 2013-08-21
First Post: 2008-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer
Sponsor: National Taiwan University Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-02
Start Date Type: None
Primary Completion Date: 2012-09
Primary Completion Date Type: ACTUAL
Completion Date: 2012-12
Completion Date Type: ACTUAL
First Submit Date: 2008-03-03
First Submit QC Date: None
Study First Post Date: 2008-03-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-08-19
Last Update Post Date: 2013-08-21
Last Update Post Date Type: ESTIMATED